Ando, K., Inagaki, C., Narita, Y., Furuta, M., Hirano, H., Esaki, T., Murotani, K., Kawakami, H., Oki, E., Muro, K. (2026). Randomized phase II trial evaluating the efficacy of zolbetuximab in the second-line for claudin18.2 positive advanced gastric/EGJ cancer patients previously treated with zolbetuximab and platinum-based chemotherapy (ZELDA trial).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps470